Back to results
TerminatedPhase 3

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

NCT02916056

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Phoenix, Arizona, United States

+70 additional locations

View on ClinicalTrials.gov
2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension) — TrialFind